Login / Signup

Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Melissa L AbelNobuyuki TakahashiCody J PeerChristophe E RedonSamantha NicholsRasa VilimasMin-Jung LeeMin-Jung LeeMeenakshi ShelatRobbie KattappuramLinda SciutoDanielle PinkiertChante GrahamDonna ButcherBaktiar O KarimAjit Kumar SharmaJustin MalinRajesh KumarChristopher W SchultzShubhank GoyalJaydira Del RiveroManan KrishnamurthyDeep UpadhyayBrett A SchroederTristan M SissungManoj TyagiJung KimYves PommierMirit I AladjemMark RaffeldWilliam Douglas FiggJane TrepelLiqiang XiParth DesaiAnish Thomas
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
ADC-based delivery of cytotoxic payloads represents a new paradigm to increase efficacy of DDR inhibitors.
Keyphrases